Clinical data
AHFS/ International Drug Names
Routes of
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
CAS Number 57149-07-2 YesY
PubChem (CID) 4418
ChemSpider 4265 N
ECHA InfoCard 100.220.557
Chemical and physical data
Formula C24H28N2O3
Molar mass 392.49 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Naftopidil (INN, marketed under the brand name Flivas) is a drug used in benign prostatic hypertrophy which acts as a selective α1-adrenergic receptor antagonist or alpha blocker.[1]

See also


  1. Sakai H, Igawa T, Onita T, Furukawa M, Hakariya T, Hayashi M, Matsuya F, Shida Y, Nishimura N, Yogi Y, Tsurusaki T, Takehara K, Nomata K, Shiraishi K, Shono T, Aoki D, Kanetake H (2011). "Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication". Hinyokika Kiyo. 57 (1): 7–13. PMID 21304253.

This article is issued from Wikipedia - version of the 6/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.